Collaboration

Blood cells
#Artificial intelligence (AI) #Collaboration #Haematology #Intelligent OMICS #Janssen #Multi-omics #Oncology

Intelligent OMICS and Janssen enter AI research collaboration

AI drug discovery company Intelligent OMICS and Janssen Research & Development have agreed a target discovery collaboration to evaluate novel biological targets for the treatment of haematological cancers. The collaboration will combine Intelligent OMICS’ AI platform, which uses multi-omics data and deep learning algorithms to uncover… Read More

#Business & Investment #News

Diversity equity inclusion
#Collaboration #Diversity

Diversity, Equity, and Inclusion Data Service for clinical development 

Phesi, a global provider of patient-centric data software and services, has partnered with Krystelis, a provider of medical writing and clinical trial transparency services, to launch its new Diversity, Equity, and Inclusion (DEI) Data Service.   A 2022 Phesi data analysis discovered 42% of US cancer trial cohorts… Read More

#News

CRISPR gene editing
#Collaboration #CRISPR #MilliporeSigma #Muscular dystrophy #Partnership #Vita Therapeutics

CRISPR collaboration will advance cell therapy for muscular dystrophy

A new licensing agreement between Vita Therapeutics and MilliporeSigma (the US and Canada Life Science business of Merck) will see Vita leverage MilliporeSigma’s foundational CRISPR patents to advance its preclinical asset VTA-100 for limb-girdle muscular dystrophy (LGMD2A). VTA-100 utilises this CRISPR genome editing technology to insert… Read More

#Business & Investment #News

#Cancer research #CAR-T #Cell and gene therapy #Collaboration #Oncology #Solid tumours

New DDW Highlights podcast now live

The latest episode of the DDW Highlights podcast is now available to listen to below. DDW’s Megan Thomas narrates five key stories of the week to keep DDW subscribers up-to-date on the latest industry updates.  The news headlines this week reflect the level of interest in cell & gene… Read More

#News

#Cancer research #CAR-T #Cell and gene therapy #Collaboration #Oncology #Solid tumours

This week in drug discovery (7-11 August)  

News round-up for by DDW Digital Content Editor Diana Spencer. The news headlines this week reflect the level of interest in cell & gene therapies (CGT) in the sector, particularly CAR-T, but also the importance of research collaborations to bring these therapies to patients. Traditionally successful… Read More

#News

Antibodies
#Antibodies #Collaboration #Funding #Infectious diseases #LifeArc #Liverpool School of Tropical Medicine

Infectious diseases research fund will progress antibody therapies

Liverpool School of Tropical Medicine (LSTM) and LifeArc are partnering to launch a new Translational Development Fund to help tackle infectious diseases. LifeArc will invest £2.7 ($3.4) million into the fund, which will support the progression of new technologies and treatments for emerging viral threats and… Read More

#News

CAR-T therapy
#Cancer research #CAR-T #Collaboration #GenScript Biotech #Solid tumours #T-MAXIMUM Biotech

Collaborators agree deal to develop CAR-T therapy for solid tumours

GenScript Biotech and T-MAXIMUM Biotech have formed a strategic collaboration to develop T-MAXIMUM’s CAR-T cell therapy using GenScript’s CRISPR nucleic acid reagents. GenScript will provide various CRISPR reagents to support the development of the universal CAR-T products from discovery to commercialisation. T-MAXIMUM Biotech hopes… Read More

#Business & Investment #News

AIDS
#AIDs #American Association of Pharmaceutical Scientists #Cambridge Crystallographic Data Centre #Collaboration #Pharmaceuticals #Research

CCDC AIDS research wins AAPS pharma award 

A Cambridge Crystallographic Data Centre (CCDC) research paper has won an Outstanding Manuscript Award from the American Association of Pharmaceutical Scientists (AAPS).  The research paper, Solid-State and Surface Structures of the Conformational Polymorphic Forms of Ritonavir in Relation to their Physicochemical Properties, published in the… Read More

#News

#Biologics #Collaboration #Ginkgo Bioworks #Merck

Ginkgo and Merck collaborate to improve biologic manufacturing 

Ginkgo Bioworks and Merck have collaborated to improve the production of biologics.  Ginkgo will apply its expertise and capabilities in cell engineering, ultra high-throughput multiplexed screening, protein characterisation and process optimisation to improve production efficiency and increase yields.   “We’re thrilled to leverage our platform to… Read More

#News

#Astex Pharmaceuticals #Cancer research #Collaboration #Merck #Oncology

Astex and MSD expand cancer drug discovery collaboration

Astex Pharmaceuticals and MSD (Merck & Co) have announced an exclusive worldwide research collaboration to identify small molecule candidates with activity towards a tumour suppressor protein for the treatment of cancer. Under the terms of the agreement, Astex will apply its fragment-based drug discovery platform to… Read More

#Business & Investment #News

Heart monitor
#AAV #Cardiovascular disease #Collaboration #Evox Therapeutics #Gene therapy #Icahn School of Medicine

Research partners advance AAV gene therapy for heart disease

Evox Therapeutics has agreed a research collaboration and option agreement with the Icahn School of Medicine at Mount Sinai (Icahn Mount Sinai) in New York, NY, US. The collaboration will work on developing exosome-encapsulated AAV (exoAAV) vectors as a novel gene delivery technology aimed at improving… Read More

#News

Treg cells
#Bayer #bit bio #BlueRock Therapeutics #Collaboration #iPSC #T cell activation

BlueRock and bit.bio sign Treg therapies discovery deal

Bayer subsidiary BlueRock Therapeutics, and bit.bio have announced a collaboration to discover and manufacture regulatory T cell (Treg) based therapies. Under the terms of the agreement, bit.bio will use its machine learning discovery platform to identify transcription factor (TF) combinations for reprogramming iPSCs into Tregs. Read More

#News

Scientist Loads Samples Into Mercury
#AI / data analytics / healthtech / informatics #Arrayjet #Assay development & optimisation #Chemspace #Collaboration #High throughput screening

Arrayjet announces collaboration with Chemspace

Arrayjet and Chemspace have agreed a partnership to augment and streamline Chemspace’s small molecule microarray (SMM) service offering. Chemspace’s compound libraries are now accessible through Arrayjet’s SMM CRO/CMO services for assay development, contract screening and contract array manufacturing. SMMs enable high-throughput screening of compound… Read More

#News

Tau proteins
#Alzheimer's #Collaboration #Neurodegenerative disorders #Neuroscience #Tau protein

Collaborators pursue anti-tau therapy for neurodegeneration

IRBM, Rainwater Charitable Foundation and Weill Cornell Medicine will start of a multi-year drug discovery collaboration to identify small molecule cGAS (cyclic GMP-AMP synthase) inhibitors for the treatment of tauopathies and other neurodegenerative diseases. The collaboration brings together IRBM’s capabilities in drug discovery and development, RCF’s… Read More

#News

Vaccine production
#Collaboration #Immunology / Virology & Vaccines #Lifera #Manufacturing #Sanofi #Saudi Arabia

Partners agree to boost vaccine accessibility in Saudi Arabia

Saudi Arabian company Lifera is partnering with Sanofi and Arabio to strengthen local manufacturing of vaccines in Saudi Arabia. Under the terms of the Memorandum of Understanding (MOU), Lifera, Sanofi and Arabio will explore opportunities for collaboration to help advance Saudi Arabia’s vaccines localisation strategy through… Read More

#News